Drug intelligence / Profile preview

estradiol + megestrol acetate

Development stage
Unknown
Lead developer
Chinese state research institutions
Modality
Small Molecules
Administration
Intramuscular
01

Overview

Estradiol + megestrol acetate is a **combined injectable contraceptive** used primarily in China under the names Chinese injectable No. 2 and Mego-E. Each injection contains 3.5 mg of estradiol (an estrogen) and 25 mg of megestrol acetate (a progestin, formulated as a microcrystalline aqueous suspension. It is administered by intramuscular injection once per month. This combination works by suppressing ovulation and modifying the endometrium, thus providing effective hormonal birth control. Developed and marketed in China, the product was widely distributed between 1980 and 2005–2008 but is now discontinued.

Brand names
Mego-EChinese injectable No. 2
Other names
estradiol/megestrol acetate
02

Targets

MR (Mineralocorticoid receptor)ER (Estrogen receptor)PR (Progesterone receptor)GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on estradiol + megestrol acetate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on estradiol + megestrol acetate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call